Clinical Trial Update: Early Versus Routine Caffeine Administration in Extremely Preterm Neonates [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating early versus routine caffeine administration in extremely preterm neonates has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extremely Preterm Neonate-related Respiratory Conditions
• Neonatal Apnea of Prematurity

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: Sharp HealthCare | Conditions: Caffeine | Phase 4 | Status: COMPLETED | Results posted: 2017-08-01